<DOC>
	<DOC>NCT02352051</DOC>
	<brief_summary>The aim of this study was to evaluate and compare the effects of Atomoxetine(ATX) and osmotic release oral system-methylphenidate (OROS-MPH) therapies on executive functions, activities, treatment response time and adverse effects based on discernible clinical effects in children with combined type attention deficit-hyperactivity disorder (ADHD).</brief_summary>
	<brief_title>Effects of Atx and Oros-mph on Executive Functions</brief_title>
	<detailed_description>The aim of this study was to evaluate and compare the effects of Atomoxetine(ATX) and osmotic release oral system-methylphenidate (OROS-MPH) therapies on executive functions, activities, treatment response time and adverse effects based on discernible clinical effects in children with combined type attention deficit-hyperactivity disorder (ADHD). In this study, the functional capabilities of the patients who clinically responded well to therapy were assessed simultaneously with clinical response that may appear at different time periods and the treatment groups were compared in patients who responded to therapy by excluding patients with insufficient clinical response.</detailed_description>
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Combined type ADHD diagnosis was made by a child psychiatrist according to DSMIV criteria through KSADS interview with the patient and mother The Clinical Global Impression Scale (CGIS) was applied to determine ADHD severity and patients with a CGIS scoreâ‰¥4 Psychological, neurological or psychiatric diseases other than ADHD, ADHD types other than combined type, Medication that influences cognitive processes or history of such medication, WISCR scores &lt;80 or &gt;120</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>attention deficit-hyperactivity disorder (ADHD).</keyword>
	<keyword>executive functions</keyword>
</DOC>